Results 181 to 190 of about 5,275,603 (391)

Optimizing extracellular matrix for endothelial differentiation using a design of experiments approach. [PDF]

Sci Rep
Hall ML, Lin WH, Ogle BM.
europepmc   +1 more source

Design of selection experiments for comparing alternative testing regimes [PDF]

, 1978
William G. Hill
openalex   +1 more source

Beyond cytotoxic T cells: reprogrammed regulatory T cells help facilitate response to dual checkpoint blockade

Molecular Oncology, EarlyView.
Rolig, Peng, and colleagues have shed new light on how dual blockade of PD1 and LAG3 enhances antitumor immunity. They found that response to immunotherapy with anti‐PD1 + anti‐LAG3 was associated with reprogramming of canonically suppressive CD4+ regulatory T cells to an inflammatory state.
Tullia C. Bruno, Anthony R. Cillo
wiley   +1 more source

MINE: a new way to design genetics experiments for discovery. [PDF]

Brief Bioinform
Torres I, Zhang S, Bouffier A, Skaro M, Wu Y, Stupp L, Arnold J, Chung YA, Schuttler HB.   +8 more
europepmc   +1 more source

A Note on Orthogonal Partitions and Some Well-Known Structures in Design of Experiments [PDF]

, 1977
Dennis Gilliland
openalex   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source

A Practical Start-Up Guide for Synthetic Chemists to Implement Design of Experiments (DoE). [PDF]

ACS Catal
Wall BJ, Koeritz MT, Stanley LM, VanVeller B.   +3 more
europepmc   +1 more source

Statistics in the Design and Analysis of Physiology Experiments

, 1965
L.D. Van Vleck, Charles Henderson
openalex   +2 more sources

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

Molecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim, Sungwoo Bae, Jaeyong Choi, Sun‐Wha Im, Bukyoung Cha, Gyeongseo Jung, Sun Wook Cho, Eul‐Ju Seo, Young Ah Lee, Jin Chul Paeng, Young Joo Park, Jong‐Il Kim   +11 more
wiley   +1 more source

Effective Design for Experiments on Small-Group Conversation: Insights From an Example Study. [PDF]

Am J Audiol
Nicoras R, Buck B, Fischer RL, Godfrey M, Hadley LV, Smeds K, Naylor G.   +6 more
europepmc   +1 more source